No, that’s not a spelling error. Learn more about the potential role Generally Regarded As Safe (GRAS)-like agents may play in enhancing glycemic control or improving the anti-inflammatory process in people with type 1 diabetes. You can listen to an interview on Diabetes Radio with Mark Atkinson, PhD, Desmond Schatz, MD, and Robert Levine, MD, or read about GRAS in the American Diabetes Association publication, Diabetes.